SECsense Logo

Royalty Pharma plc 8-K Report: Key Updates Revealed on January 13, 2025

$RPRX
Form 8-K
Filed on: 2025-01-13
Source
Royalty Pharma plc 8-K Report: Key Updates Revealed on January 13, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Company Information:
  • Entity: Royalty Pharma plc
  • CIK Number: 0001802768
  • SEC Filing Type: 8-K
  • Date of Filing: January 13, 2025
  • Address: 110 East 59th Street, New York, NY 10022
  • Phone Number: (212) 883-0200
  1. Stock Information:
  • Trading Symbol: RPRX
  • Exchange: NASDAQ
  • Class of Shares: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  1. Filing Context:
  • Reporting Period: The context indicates a single day reporting period starting and ending on January 13, 2025.
  1. Document Metadata:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting and regulatory filings.
  1. Regulatory Information:
  • The filing is intended to comply with SEC regulations, as indicated by the presence of the CIK and the use of XBRL.

Based on this information, it appears that Royalty Pharma plc is submitting a Form 8-K, which typically reports unscheduled material events or corporate changes that are important to shareholders. The filing is likely to contain significant updates or announcements that warrant immediate disclosure to investors.